Skip to main content
Genus plc (LON:GNS)
London flag London · Delayed Price · Currency is GBP · Price in GBX
2,590.00
-60.00 (-2.26%)
At close: Dec 5, 2025

Genus Revenue

In the fiscal year ending June 30, 2025, Genus had annual revenue of 672.80M GBP with 0.60% growth. Genus had revenue of 336.40M in the half year ending June 30, 2025, a decrease of -0.91%.

Revenue
672.80M
Revenue Growth
+0.60%
P/S Ratio
2.58
Revenue / Employee
210.91K
Employees
3,190
Market Cap
1.73B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Jun 30, 2025672.80M4.00M0.60%
Jun 30, 2024668.80M-20.90M-3.03%
Jun 30, 2023689.70M96.30M16.23%
Jun 30, 2022593.40M19.10M3.33%
Jun 30, 2021574.30M22.90M4.15%
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AstraZeneca 43.24B
GSK plc 32.17B
Haleon 11.02B
Smith & Nephew 4.33B
Convatec Group 1.72B
Hikma Pharmaceuticals 2.35B
HUTCHMED (China) 439.54M
Oxford Nanopore Technologies 204.69M
Revenue Rankings

Genus News

More News